Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota
Objective: To assess distal functional gastrointestinal (GI) symptoms and their connection to fecal microbiota (FM) in Parkinson (PD) patients. Background: The majority of PD patients…Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease
Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease
Objective: To evaluate (1) the changes of non-motor symptoms such as depression, sleep disorders, pain and cognitive deficits in PD by practicing LSVT BIG therapy…Clinical profile and outcome of hospitalized patients with Parkinson’s disease
Objective: In this study we explored the cause of hospitalization, clinical course and outcome among Parkinson's disease (PD) patients. Background: Patients with PD are frequently…Headache in patients with Parkinsons disease: Pilot study results
Objective: Investigate the prevalence and characteristics of headache in PD patients, acknowledge the existing relation within the predominant laterality of the headache and side of…Disease-related variables effect on depression and anxiety level in Parkinson’s patients
Objective: To evaluate correlations of depression and anxiety levels with motor symptoms, non-motor symptoms and pharmacological factors in Parkinson's disease (PD). Background: Depression and anxiety…Non-motor outcomes of subthalamic stimulation in Parkinson’s disease depend on the location of active contacts
Objective: To investigate the impact of active electrode contact location on non-motor outcomes in patients with Parkinson's disease (PD) and subthalamic nucleus (STN) deep brain…A new tool to measure the impact of deep brain stimulation on Parkinson’s disease patients: Development and validation of the deep brain stimulation impairment scale (DBS-IS)
Objective: To develop a questionnaire that measures impairments related to deep brain stimulation (DBS). Background: DBS has considerable influence on motor and non-motor symptoms in…Longitudinal assessment of sleep in an incident Parkinson’s disease cohort
Objective: To evaluate subjective and objective measures of sleep disturbance in an incident PD cohort over longitudinal follow-up. Background: Sleep disturbance is widely recognised as…Non-motor symptoms in advanced Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel, deep brain stimulation, or continuous subcutaneous apomorphine: A systematic literature review and pooled analysis
Objective: To systematically review literature reporting changes in non-motor symptoms (NMS) among patients with advanced PD (APD) treated with levodopa/carbidopa intestinal gel (LCIG), deep brain…
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 51
- Next Page »